Pricing Log in Create free account
Friday 6 November 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

IOVA Healthcare Biotechnology

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024.

Revenue
+80.1%
EPS
+80.0%
Free cash flow
+89.7%

Quarter to September 2026, against a year earlier

7.99 0.25 +3.23%
Market cap
$3.5B
P/E
0.0×
Fwd P/E
−18.9×
Dividend yield
—
F-score
4/9
Altman Z
−2.30
Beneish M
−2.46
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Iovance Biotherapeutics, Inc. (IOVA) Current ratio

Alert me on Current ratio

Iovance Biotherapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 5.2×, up 2.0× from fiscal 2025 (3.2×). Over the past ten years it has ranged from 2.8× (fiscal 2023) to 63.8× (fiscal 2015); the current reading is higher than 18% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 3.2× (14.35%)
FY2024 3.7× 33.85%
FY2023 2.8× (46.71%)
FY2022 5.2× (8.03%)
FY2021 5.7× (50.88%)
FY2020 11.6× 43.16%
FY2019 8.1× (75.47%)
FY2018 33.0× 112.20%
FY2017 15.6× (54.40%)
FY2016 34.1× (46.51%)

Quarterly newest first

Period Current ratio Change
Sep 2026 5.2× 19.59%
Jun 2026 4.3× 20.54%
Mar 2026 3.6× 12.66%
Dec 2025 3.2× (6.21%)
43 more quarters

Against its own ten years

Low 2.8× High 63.8×
Ten-year median 8.1×
Current reading's percentile 18

Current ratio against peers

Company Current ratio
TNGX Tango Therapeutics, Inc. compare 50.8×
IRON Disc Medicine, Inc. compare 24.1×
XENE Xenon Pharmaceuticals Inc. compare 21.0×
RLAY Relay Therapeutics, Inc. compare 18.3×
PBLS Parabilis Medicines, Inc. compare 17.9×
EWTX Edgewise Therapeutics, Inc. compare 16.2×
ABCL AbCellera Biologics Inc. compare 12.8×
IOVA Iovance Biotherapeutics, Inc. 5.2×
ACAD ACADIA Pharmaceuticals Inc. compare 3.8×
Biotechnology industry median 4.9×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on IOVA